中文 | English
Return
Total: 61 , 1/7
Show Home Prev Next End page: GO
Author:(Fu-lan HAN)

1.Effect of Astragalus on T Lymphocyte Immune Function in Immature Rats with Obstructive Jaundice

Zhaodong HAN ; Yueqin RUAN ; Lan ZHANG ; Qizhong FAN ; Tingliang FU

International Journal of Traditional Chinese Medicine 2008;30(2):87-89

3.Effect of Danshen-containing serum on expression of SuFu and DYRK2 in HSCs.

Shi-qing HAN ; Hai-lan WANG ; Li-li FENG ; Wen-fu CAO

China Journal of Chinese Materia Medica 2015;40(22):4469-4474

4.Tankyrase expression in lung bronchiolo-alveolar adenocarcinoma and its relationship with the WNT pathway

Chong LI ; Xu ZHENG ; Yanyan HAN ; Yan LYU ; Fu LAN ; Jie ZHAO

Tianjin Medical Journal 2016;44(6):733-735,652

6.Value of autotaxin in predicting refractory Mycoplasma pneumoniae pneumonia in children and its correlation with inflammatory cytokines.

Bin-Bin FU ; Lan-Lan ZHONG ; Ting-Ting YE ; Yan-Mei HAN ; Xiao-Cui QIU

Chinese Journal of Contemporary Pediatrics 2022;24(7):765-770

7.Auricular acupuncture for primary insomnia: a systematic review based on GRADE system.

Hui-Juan TAN ; Ying LAN ; Fu-Sheng WU ; Han-Dan ZHANG ; Li WU ; Xi WU ; Fan-Rong LIANG

Chinese Acupuncture & Moxibustion 2014;34(7):726-730

8.Expression, purification and characterization of the recombinant anthrax protective antigen.

Jun-Jie XU ; Da-Yong DONG ; Xiao-Hong SONG ; Meng GE ; Guan-Lin LI ; Ling FU ; Han-Lan ZHUANG ; Wei CHEN

Chinese Journal of Biotechnology 2004;20(5):652-655

9.Studies on triterpenoid constituents from Rabdosia japonica var. galaucocalyx.

Fu-Dong WANG ; Lan DING ; Han-Qing WANG

China Journal of Chinese Materia Medica 2005;30(24):1929-1932

10.IFN or oxymatrine in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Ping ZHAO ; Han-wei LI ; Min LOU ; Yong-qian CHENG ; Yun LAN ; Jun-liang FU

Chinese Journal of Experimental and Clinical Virology 2004;18(1):80-82

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 61 , 1/7 Show Home Prev Next End page: GO